Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2013 AND VI 52 AND IP 4
Results: 7
1
2
Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 243, doi. 10.1007/s40262-013-0034-0
- By:
- Publication type:
- Article
3
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer's Disease.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 225, doi. 10.1007/s40262-013-0038-9
- By:
- Publication type:
- Article
4
Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 277, doi. 10.1007/s40262-013-0037-x
- By:
- Publication type:
- Article
5
Population Pharmacokinetics of Tranexamic Acid in Paediatric Patients Undergoing Craniosynostosis Surgery.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 267, doi. 10.1007/s40262-013-0033-1
- By:
- Publication type:
- Article
6
Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic Fibrosis.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 289, doi. 10.1007/s40262-013-0036-y
- By:
- Publication type:
- Article
7
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 255, doi. 10.1007/s40262-013-0035-z
- By:
- Publication type:
- Article